Search research articles
Contact Us
Filters
Showing results (361-370 of 370) with videos related to
Page
of 37
Sort By:
You have reached the last page of results.
This site can display upto 370 results.
ESMO Open
|
December 23, 2021
Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study
E M Ruggeri, F Nelli, A Fabbri, et al.
ESMO Open
|
January 10, 2021
Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy
M Ganzinelli, H Linardou, M F Alvisi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 31, 2006
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
L Arcaini, S Burcheri, A Rossi, et al.
Breast (Edinburgh, Scotland)
|
August 1, 2016
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience
L Moscetti, P Vici, T Gamucci, et al.
ESMO Open
|
December 1, 2022
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers
G Lo Russo, F Sgambelluri, A Prelaj, et al.
Pulmonology
|
February 22, 2022
Diagnostic role of internal mammary lymph node involvement in tuberculous pleurisy: a multicenter study
G Levi, C Rocchetti, F Mei, et al.
Journal of Endocrinological Investigation
|
May 22, 2019
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
M Caprio, M Infante, E Moriconi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2024
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)
C Proto, M Ganzinelli, S Manglaviti, et al.
NPJ Precision Oncology
|
April 10, 2026
The role of the molecular tumor board: learnings from the ROME trial
P Marchetti, G Curigliano, C B Westphalen, et al.
International Journal of Cancer
|
July 23, 2019
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting
Laura Pizzuti, Eriseld Krasniqi, Giacomo Barchiesi, et al.
Page
of 37
Search research articles
Search
Showing results (361-370 of 370) with videos related to
Sort By:
Page
of 37
You have reached the last page of results.
This site can display upto 370 results.
ESMO Open
|
December 23, 2021
Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study
E M Ruggeri, F Nelli, A Fabbri, et al.
ESMO Open
|
January 10, 2021
Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy
M Ganzinelli, H Linardou, M F Alvisi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 31, 2006
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
L Arcaini, S Burcheri, A Rossi, et al.
Breast (Edinburgh, Scotland)
|
August 1, 2016
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience
L Moscetti, P Vici, T Gamucci, et al.
ESMO Open
|
December 1, 2022
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers
G Lo Russo, F Sgambelluri, A Prelaj, et al.
Pulmonology
|
February 22, 2022
Diagnostic role of internal mammary lymph node involvement in tuberculous pleurisy: a multicenter study
G Levi, C Rocchetti, F Mei, et al.
Journal of Endocrinological Investigation
|
May 22, 2019
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
M Caprio, M Infante, E Moriconi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2024
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)
C Proto, M Ganzinelli, S Manglaviti, et al.
NPJ Precision Oncology
|
April 10, 2026
The role of the molecular tumor board: learnings from the ROME trial
P Marchetti, G Curigliano, C B Westphalen, et al.
International Journal of Cancer
|
July 23, 2019
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting
Laura Pizzuti, Eriseld Krasniqi, Giacomo Barchiesi, et al.
Page
of 37